Revance

Pharma

Hoping to challenge AbbVie's Botox, Revance cuts Daxxify's price

Revance has rolled out a new strategy for Daxxify, revealing a drop in price that the company says will allow it to challenge AbbVie powerhouse Botox.

Kevin Dunleavy Sep 20, 2023 8:40am

AbbVie's Botox aces phase 3 study in another cosmetic use

Sep 18, 2023 3:05pm

Revance's Daxxify scores first FDA approval for therapeutic use

Aug 14, 2023 2:16pm

Revance wants you to 'Break Up With Botox' in new AbbVie battle

Jun 29, 2023 9:25am

In cosmetic treatment battle, AbbVie sues Revance—again

May 3, 2023 3:04pm

AbbVie taps 25 real consumers of Botox 'See Yourself' campaign

Sep 22, 2022 8:55am